The hypoxic tumour microenvironment and metastatic progression

The microenvironment of solid tumours contains regions of poor oxygenation and high acidity. Growing evidence from clinical and experimental studies points to a fundamental role for hypoxia in metastatic progression. Prolonged hypoxia increases genomic instability, genomic heterogeneity, and may act as a selective pressure for tumour cell variants. Hypoxia can also act in an epigenetic fashion, altering the expression of genes. Hypoxia-induced changes in gene expression alter non-specific stress responses, anaerobic metabolism, angiogenesis, tissue remodeling, and cell–cell contacts. Experimental studies have demonstrated that inhibition of proteins involved in these processes can modify metastasis formation, suggesting a causal role in metastatic progression. Recent advances in high-throughput screening techniques have allowed identification of many hypoxia-induced genes that are involved in the processes associated with metastasis. Here we review the epigenetic control of gene expression by the hypoxic microenvironment and its potential contribution to metastatic progression.

[1]  P. Friedl,et al.  The biology of cell locomotion within three-dimensional extracellular matrix , 2000, Cellular and Molecular Life Sciences CMLS.

[2]  I. Fidler,et al.  Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  J. Norgauer,et al.  Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. , 1996, Journal of immunology.

[4]  M. Horsman,et al.  Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review. , 1995, Acta oncologica.

[5]  D. Schadendorf,et al.  IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.

[6]  R. Airley,et al.  Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  J. Vaage A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors , 1989, International journal of cancer.

[8]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[9]  R. Hill,et al.  Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. , 1990, Journal of the National Cancer Institute.

[10]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[11]  A. Harris,et al.  Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling , 2000, Oncogene.

[12]  H. Lyng,et al.  Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.

[13]  T. Curran,et al.  Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. , 1994, Molecular and cellular biology.

[14]  J. Purdy,et al.  Quality assurance for 3D conformal radiation therapy. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[15]  Berk,et al.  Scale-invariant behavior and vascular network formation in normal and tumor tissue. , 1995, Physical review letters.

[16]  G. Semenza,et al.  Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.

[17]  E. Rofstad,et al.  Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8 , 2002, British Journal of Cancer.

[18]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[19]  S. Eccles,et al.  Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis , 2001, Cancer.

[20]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[21]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[22]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[23]  O. Hankinson,et al.  Identification of genes differentially induced by hypoxia in pancreatic cancer cells. , 2001, Biochemical and biophysical research communications.

[24]  J. Slavin,et al.  Fibroblast growth factors: at the heart of angiogenesis. , 1995, Cell biology international.

[25]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[26]  A. Harris,et al.  Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.

[27]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[28]  M. Gassmann,et al.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.

[29]  R. Hill Tumor progression: Potential role of unstable genomic changes , 1990, Cancer and Metastasis Reviews.

[30]  A. Harris,et al.  The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. , 1997, Cancer research.

[31]  E. Rofstad,et al.  Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. , 2002, Cancer research.

[32]  L. Poellinger,et al.  Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. , 2002, Blood.

[33]  C. Rinker-Schaeffer,et al.  Metastasis-suppressor genes: a review and perspective on an emerging field. , 2000, Journal of the National Cancer Institute.

[34]  U. Staedt,et al.  Substrate balances across colonic carcinomas in humans. , 1995, Cancer research.

[35]  Eamonn R. Maher,et al.  Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.

[36]  R. Cardiff,et al.  Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice , 2001, Oncogene.

[37]  I. Nabi,et al.  Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells. , 2000, Biochemical and biophysical research communications.

[38]  Erwin G. Van Meir Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. , 1996, Neurosurgery.

[39]  R. Pötter,et al.  Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  A. Harris,et al.  Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.

[41]  H. Lyng,et al.  Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis , 2000, British Journal of Cancer.

[42]  A. Harris,et al.  The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer , 2002, British Journal of Cancer.

[43]  Alan Cantor,et al.  Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. , 2002, Journal of the National Cancer Institute.

[44]  L. Ellis,et al.  Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice , 2004, Clinical & Experimental Metastasis.

[45]  S. Dedhar,et al.  The integrin-linked kinase (ILK) suppresses anoikis , 2000, Oncogene.

[46]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[47]  Y. Zou,et al.  Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia* , 1997, The Journal of Biological Chemistry.

[48]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[49]  E. Rofstad,et al.  Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. , 2000, Cancer research.

[50]  A. Harris,et al.  Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  E. Rofstad,et al.  Correlation of high lactate levels in human cervical cancer with incidence of metastasis. , 1995, Cancer research.

[52]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[53]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  K. Matsushima,et al.  Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[55]  T. Kawamoto,et al.  Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. , 1997, Biochemical and biophysical research communications.

[56]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[57]  A. Hartmann,et al.  Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. , 1999, Cancer research.

[58]  K. Webster,et al.  Hypoxia Regulates β-Enolase and Pyruvate Kinase-M Promoters by Modulating Sp1/Sp3 Binding to a Conserved GC Element* , 1998, The Journal of Biological Chemistry.

[59]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[60]  T. E. Fitzpatrick,et al.  Effect of hypoxia on cellular adhesion to vitronectin and fibronectin. , 2001, Biochemical and biophysical research communications.

[61]  T. Kawamoto,et al.  Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway. , 2001, European journal of cell biology.

[62]  A. Koong,et al.  Epigenetic Regulation of Gene Expression in Cervical Cancer Cells by the Tumor Microenvironment 1 , 2000 .

[63]  C. Graham,et al.  Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. , 2001, Experimental cell research.

[64]  P. Ratcliffe,et al.  Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.

[65]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[66]  T. Veikkola,et al.  Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.

[67]  S. Fox,et al.  Thymidine phosphorylase is angiogenic and promotes tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[69]  D. Hedley,et al.  Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[71]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[72]  Y. S. Kim,et al.  Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. , 2001, Cancer research.

[73]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.

[74]  P. Glazer,et al.  Genetic instability induced by the tumor microenvironment. , 1996, Cancer research.

[75]  G. Semenza,et al.  Molecular basis of hypoxia‐induced erythropoietin expression , 1996, Current opinion in hematology.

[76]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[77]  E. Rofstad,et al.  Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. , 2002, Cancer research.

[78]  H. Lyng,et al.  Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[79]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[80]  A. Fyles,et al.  Interstitial Fluid Pressure in Cervical Cancer: Guide to Targeted Therapy , 2001, American journal of clinical oncology.

[81]  T. Danielsen,et al.  Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis , 1999, British Journal of Cancer.

[82]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[83]  J. Winstanley,et al.  Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. , 2002, Cancer research.

[84]  A. Hartmann,et al.  Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. , 1999, The American journal of pathology.

[85]  M. Dewhirst,et al.  Concepts of oxygen transport at the microcirculatory level. , 1998, Seminars in radiation oncology.

[86]  L. Liotta,et al.  Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration , 1987, Nature.

[87]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[88]  M Hubank,et al.  Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.

[89]  F. Howe,et al.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.

[90]  G. Semenza,et al.  HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.

[91]  E. Rofstad,et al.  High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.

[92]  A. Harris,et al.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[93]  M. Bar‐eli Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma , 1999, Pathobiology.

[94]  R. Strausberg,et al.  Transcriptional response to hypoxia in human tumors. , 2001, Journal of the National Cancer Institute.

[95]  O. S. Nielsen,et al.  Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations , 2001, British Journal of Cancer.

[96]  L. Liotta,et al.  Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: Human melanoma and ras‐transfected NIH3T3 cells , 1991, International journal of cancer.

[97]  I. Tannock,et al.  The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. , 1998, British Journal of Cancer.

[98]  A. Maity,et al.  Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia. , 2000, Experimental cell research.

[99]  J. Overgaard,et al.  Techniques to assess the oxygenation of human tumors. State of the art. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[100]  R. Khokha,et al.  Anoikis and metastatic potential of cloudman S91 melanoma cells. , 2001, Cancer research.

[101]  K. Webster,et al.  Physical and functional sensitivity of zinc finger transcription factors to redox change , 1996, Molecular and cellular biology.

[102]  J. Marshall,et al.  Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. , 1998, British Journal of Cancer.

[103]  G. Semenza,et al.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.

[104]  D. Schatz,et al.  cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. , 1999, Methods in enzymology.

[105]  Michael V. Doyle,et al.  Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.

[106]  P. Okunieff,et al.  Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. , 1989, Cancer research.

[107]  A. Koong,et al.  Candidate genes for the hypoxic tumor phenotype. , 2000, Cancer research.

[108]  R. Khokha,et al.  Steps in tumor metastasis: new concepts from intravital videomicroscopy , 1995, Cancer and Metastasis Reviews.

[109]  R. Hill,et al.  Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[110]  N. Brünner,et al.  Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[111]  T Shinozaki,et al.  Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.

[112]  A. Koong,et al.  Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. , 1994, Cancer research.

[113]  M. Lerman,et al.  Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.

[114]  S. Macdonald-Goodfellow,et al.  Hypoxia‐mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression , 1999, International journal of cancer.

[115]  T. E. Fitzpatrick,et al.  Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. , 1998, Blood.

[116]  J. Overgaard,et al.  Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. , 1996, Seminars in radiation oncology.

[117]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[118]  H. Birnboim,et al.  Mutagenicity and cytotoxicity of reactive oxygen and nitrogen species in the MN-11 murine tumor cell line. , 1997, Mutation research.

[119]  S. De Flora,et al.  ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[120]  M. W. D. Dvm Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .

[121]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. , 2000, Cancer research.

[122]  G. Semenza,et al.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.

[123]  J. Alam,et al.  Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. , 2001, International journal of oncology.

[124]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[125]  R. Hill,et al.  An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells , 1997, Clinical & Experimental Metastasis.

[126]  L. Ellis,et al.  Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. , 2001, Cancer biotherapy & radiopharmaceuticals.

[127]  A Dietz,et al.  Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[128]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[129]  C. Bucana,et al.  Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity. , 2000, Cytokines, cellular & molecular therapy.

[130]  R. Hill,et al.  Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.

[131]  I. Tannock,et al.  Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[132]  J. Isaacs,et al.  CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. , 1997, Cancer research.

[133]  M Molls,et al.  Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.